Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Interim Management Statement

21 May 2010 07:00

RNS Number : 3118M
S & U PLC
21 May 2010
Β 

ο»Ώ

21 May 2010

Β 

Interim Management Statement

Β 

Β 

Β 

S&U, Britain's foremost niche home credit and motor finance provider, today issues an interim management statement for the period from 1 February 2010 to 20 May 2010, ahead of its Annual General Meeting being held later today.

Β 

Home Credit

Loansathome4u, our home credit business, increased revenues by 2% in this period versus the same period last year which reflects a 4% growth in customer numbers offset by continued customer borrowing caution in the current economic climate. Collections have remained robust, being up by over 3% on last year with impairment charges being reduced by 2%. These results are testimony to the well-established and mutually beneficial relationships our representatives have with our customers. Administrative expenses are stable but will reflect an extra Β£350,000 charge in the first half year due to accelerated remuneration payments made before the Government tax legislation changes at the end of March 2010. This Β£350,000 charge will reverse in the second half year.

Β 

Motor Finance

Advantage, our motor finance business, has followed up on a strong finish to the last financial year with an excellent start to this financial year. In a less competitive market, new business written is up over 40% on the same period last year and initial repayment quality continues to be higher in line with recent trends. Revenues are up over 20% on the same period last year, whilst impairment charges have only risen by 11% and overall collections are good. Early redemptions continue to be lower than last year and current levels of profitability are encouraging.

Β 

Funding and Capital

S&U's financial position is strong and becoming stronger. Since the year end Group borrowings have been reduced to Β£26.1m (May 2009: Β£27.6m) as the trading cash generated has more than funded good motor finance growth and covered Β£2.4m of accelerated dividend and remuneration payments made in the first quarter. We anticipate that Group borrowings should reduce further in the second quarter, increasing the likely headroom available for further organic growth and acquisition.

Β 

Outlook

S&U is cautiously optimistic about the outlook and is trading in line with its expectations for the year to date.

Β 

S&U will issue a further trading update following its half year ending 31 July 2010. The interim results are scheduled for release towards the end of September 2010.

Β 

Commenting, Mr Anthony Coombs, S&U Chairman, said:

Β 

"Whilst economic conditions will take time to become more certain, the resilience of our own performance and current positive trading trends give cause for continued cautious optimism."

Β 

For further information, please contact:

Β 

S&U plc www.suplc.co.ukΒ 

Anthony Coombs, Chairman 0121 705 7777

Β 

Charles Stanley Securities

Mark Taylor / Dugald Carlean 020 7149 6000

Β 

Smithfield

Rupert Trefgarne/ Rebecca Whitehead 020 7360 4900

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSMMGZKLGZGGZM
Date   Source Headline
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement
7th Dec 20217:00 amRNSBlock Listing Application
23rd Nov 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Oct 20219:46 amRNSDirector/PDMR Shareholding
6th Oct 20217:00 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim Results
22nd Sep 20217:00 amRNSInvestor Presentation
10th Aug 20217:00 amRNSTrading Update and Notice of Results
23rd Jul 20214:50 pmRNSDirector/PDMR Shareholding
30th Jun 20214:02 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 202110:00 amRNSResult of AGM
20th May 20217:00 amRNSAGM Statement and Trading Update
23rd Apr 20211:00 pmRNSAnnual Report and Accounts
16th Apr 20215:37 pmRNSDirector/PDMR Shareholding and Total Voting Rights
14th Apr 20219:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.